BeyondSpring (BYSI) Prices 1.93M Share Common Offering at $13/Sh
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/2/2026
- Wall St futures rise ahead of jobs report as bond market steadies, oil slips
- Nvidia returns as Morgan Stanley’s Top Pick on attractive valuation
- Fed’s Jefferson sees no urgency for another rate increase
- Amazon and these four U.S. stocks are latest additions to Goldman’s flagship list
- Anthropic targets mid-November for public debut - report
- DataMeds AI's Corexa Pharmacy tops $1M in monthly revenue
- Equities rebound to close higher as surging Treasury yields recede
- Twilio, Vylor set to join S&P 500 as index reshuffles members
- onsemi cuts Synaptics deal price to $5.7B after rival bid
- Wells Fargo names 13 stocks as overweight tactical ideas
BeyondSpring Announces Pricing of Ordinary Shares
June 19, 2020 5:31 AM EDTNEW YORK, June 19, 2020 (GLOBE NEWSWIRE) -- BeyondSpring Inc. (the Company or BeyondSpring) (Nasdaq: BYSI), a global biopharmaceutical company focused on the development of innovative immuno-oncology cancer therapies, today announced the pricing of its public offering of 1,930,000 ordinary shares at a public offering price of $13.00 per share. The Company also announced the sale of an aggregate of 384,615 ordinary shares at the public offering price to entities affiliated with Decheng Capital in a separate private placement transaction. The gross proceeds from the public offering and the private placement are expected to be approximately $30.1 million, before deducting... More
